Group One Trading
MDGL icon

Group One Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Group One Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.58M Sell
16,400
-36,900
-69% -$17.6M 0.02% 941
2025
Q4 		$31M Sell
53,300
-12,700
-19% -$6.49M 0.05% 352
2025
Q3 		$30.3M Buy
66,000
+5,300
+9% +$1.98M 0.05% 333
2025
Q2 		$18.4M Buy
60,700
+7,300
+14% +$2.18M 0.04% 474
2025
Q1 		$17.7M Sell
53,400
-116,400
-69% -$38.2M 0.05% 360
2024
Q4 		$52.4M Buy
169,800
+15,700
+10% +$4.42M 0.12% 133
2024
Q3 		$32.7M Buy
154,100
+41,000
+36% +$10.5M 0.09% 158
2024
Q2 		$31.7M Sell
113,100
-61,800
-35% -$14.7M 0.12% 121
2024
Q1 		$46.7M Sell
174,900
-74,400
-30% -$17.5M 0.18% 70
2023
Q4 		$57.7M Buy
249,300
+119,900
+93% +$21M 0.15% 81
2023
Q3 		$18.9M Buy
129,400
+18,700
+17% +$3.52M 0.06% 250
2023
Q2 		$25.6M Buy
110,700
+70,700
+177% +$19.1M 0.08% 176
2023
Q1 		$9.69M Sell
40,000
-54,300
-58% -$14.8M 0.04% 480
2022
Q4 		$27.4M Buy
94,300
+72,900
+341% +$7.13M 0.06% 307
2022
Q3 		$1.39M Buy
21,400
+400
+2% +$27.8K ﹤0.01% 2232
2022
Q2 		$1.5M Buy
21,000
+20,900
+20,900% +$1.54M ﹤0.01% 2325
2022
Q1 		$10K Sell
100
-6,500
-98% -$548K ﹤0.01% 7159
2021
Q4 		$559K Buy
6,600
+6,400
+3,200% +$526K ﹤0.01% 4002
2021
Q3 		$16K Buy
200
+100
+100% +$8.64K ﹤0.01% 7293
2021
Q2 		$10K Hold
100
– – ﹤0.01% 7520
2021
Q1 		$12K Buy
+100
New +$11.7K ﹤0.01% 6967
2020
Q3 		– Sell
-100
Closed -$11K – 6356
2020
Q2 		$11K Buy
+100
New +$9.83K ﹤0.01% 5079
2019
Q4 		– Sell
-3,000
Closed -$259K – 5413
2019
Q3 		$259K Buy
3,000
+700
+30% +$65.7K ﹤0.01% 2897
2019
Q2 		$241K Sell
2,300
-300
-12% -$32.1K ﹤0.01% 2715
2019
Q1 		$326K Sell
2,600
-1,100
-30% -$137K ﹤0.01% 2299
2018
Q4 		$417K Buy
+3,700
New +$573K ﹤0.01% 2115
2016
Q4 		– Sell
-5,000
Closed -$63K – 4653
2016
Q3 		$63K Buy
5,000
+4,857
+3,397% +$47.1K ﹤0.01% 3210
2016
Q2 		$1K Buy
+143
New +$1.72K ﹤0.01% 4510
2016
Q1 		– Sell
-2,977
Closed -$37K – 4779
2015
Q4 		$37K Sell
2,977
-1,749
-37% -$48K ﹤0.01% 3587
2015
Q3 		$288K Buy
4,726
+503
+12% +$36.3K ﹤0.01% 2232
2015
Q2 		$330K Buy
4,223
+2,254
+114% +$189K ﹤0.01% 2147
2015
Q1 		$134K Buy
1,969
+795
+68% +$68.2K ﹤0.01% 2686
2014
Q4 		$109K Sell
1,174
-3,583
-75% -$370K ﹤0.01% 2773
2014
Q3 		$501K Buy
4,757
+3,286
+223% +$457K 0.01% 1625
2014
Q2 		$211K Sell
1,471
-609
-29% -$89K ﹤0.01% 2358
2014
Q1 		$314K Sell
2,080
-2,117
-50% -$417K 0.01% 2055
2013
Q4 		$770K Buy
4,197
+1,526
+57% +$279K 0.01% 1286
2013
Q3 		$590K Sell
2,671
-840
-24% -$179K 0.01% 1469
2013
Q2 		$613K Buy
+3,511
New +$915K 0.02% 1179

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's MDGL Position: Q1 2025 in Review

Group One Trading sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2025, closing a stake of 100,146 shares — an estimated $32.9M sold.

Group One Trading first reported a position in MDGL in Q2 2013 and held it in 30 quarters. The position peaked at $44.4M in Q4 2023. 321 funds tracked by Wall St. Rank hold MDGL as of Q1 2025.

  • Group One Trading reported no remaining Madrigal Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 100,146 Madrigal Pharmaceuticals shares in Q1 2025, an estimated $32.9M.
  • Group One Trading first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 30 quarters.
  • Group One Trading's Madrigal Pharmaceuticals position peaked at $44.4M in Q4 2023.
  • 321 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.